We can help you claim
compensation following an accident
illness or injury - nationwide
Call: 0800 10 757 95
Over the years there have been many attempts to develop new pharmaceutical treatments for the deadly asbestos cancer mesothelioma.
Now, one new proposed treatment involves the use of microRNAs therapy, a sophisticated type of gene therapy which acts on aspects of protein synthesis inherent in the pathology of cancers.
"Over the past several years, microRNAs have been hailed as one of the most significant scientific and medical discoveries. They have been described as the body's master switches, holding significant potential for therapeutic applications, and have been shown to be highly sensitive and specific biomarkers," explains Kenneth A. Berlin, President and CEO of Rosetta Genomics.
Although investigation into mesothelioma targeted microRNA therapy is only at an early stage, early assessment has revealed that the microRNA miR-31, a known suppressor of cancer metastases, is not expressed in sufferers of the asbestos cancer. By re-introducing miR-31, scientists were able to effectively suppress the proliferation of damaging cell cycle replication. This study, "Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma", was reported in The Journal of Biological Chemistry.
"This latest publication is another demonstration of microRNAs' potential role in cancer therapeutics, and details the significant impact a single microRNA can have on disease course," said Berlin.
Adding, "Through our commercially available diagnostic tests for cancer, as well as through a robust and diverse microRNA-based product pipeline, we aim to continue to lead in this field by harnessing the power of microRNAs to advance patient care worldwide."
Claim compensation for mesothelioma
Asbestosis related diseases are usually very serious; indeed cancers caused by the deadly substance are almost always fatal.
The gap between exposure to asbestos and the onset of a disease like mesothelioma can be many years. As a result, the companies where exposure was suffered can sometimes have gone out of business, making it difficult to trace the liability insurer and mount a compensation claim.
Here at YouClaim we have an outstanding track record of success in tracing insurers, pursuing claims and securing 100 percent compensation settlements for our clients.
We do this on a charge-free basis, win or lose and without taking any cuts, in any circumstances. Our personal injury solicitors are among the UK's best.
To find out more about how we can help you, echat, complete an online claim form or call us, on 0800 10 757 95.
